Therefore, this study explored the effect of metformin synergized with PD-L1 monoclonal antibody (PD-L1 MAb) in treating NSCLC at the animal level by constructing a subcutaneous transplanted tumor model of lung cancer. The gene discussed is CD274; the disease is non-small cell lung carcinoma.